Insider Trading26 Jun 2026, 04:40 pm
Jagsonpal Pharma Closes Trading Window for Q1 FY27
AI Summary
Jagsonpal Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in effect from Wednesday, July 01, 2026, and will remain until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The company will announce the date of the Board Meeting to approve these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for designated persons and immediate relatives.
- Window reopens 48 hours after Q1 FY27 results declaration.
- Compliance with SEBI Insider Trading Regulations.
- Board meeting date for results to be announced later.
Price Impact
More from JAGSNPHARM